Wednesday, December 7, 2022

ALYN Hospital Receives a $2.2M Grant

ALYN Hospital, Israel’s first and only pediatric and adolescent rehabilitation facility, has been awarded a donation of $2.189 million from The Leona M. and Harry B. Helmsley Charitable Trust, to establish the first center in Israel dedicated to groundbreaking research that will position Israel as a global leader in pediatric and adolescent rehabilitation development.

The Helmsley Charitable Trust is a global philanthropy committed to helping people live better lives today and creating stronger, healthier futures for individuals and communities. Since 2010, Helmsley has contributed over $434 million to Israel, including a donation of $12.5M last year to help fight the coronavirus pandemic.

ALYN Hospital’s new research center will focus on several relevant fields, including  cognitive, orthopedic and neurological rehabilitation, remote rehabilitation, mobility, and more. These are crucial areas to help ALYN’s young patients perform their daily activities and promote their integration into their communities. These patients are in need of rehabilitation due to various circumstances, such as accidents, diseases, birth defects, and developmental issues (such as cerebral palsy).  With the new research center, ALYN Hospital will be able to advance its treatment methods and approach. The research will be conducted in collaboration with other hospitals and organizations in Israel and around the world.

Arie Melamed, General Manager of ALYNnovation, the hospital’s innovation center, has been appointed as the Director of the Research Center, while Prof. Patrice L. (Tamar) Weiss, a world-renowned expert in the field of rehabilitation, will oversee the center’s scientific activities.

Sandor Frankel, a Helmsley Trustee, stated: “Helmsley is pleased to support ALYN Hospital, a distinguished institution qualified to lead the necessary research activities in the field of pediatric and adolescent rehabilitation in Israel, helping millions of young patients in the country and around the world who need innovative and groundbreaking treatments.”

“The new research center will allow us to expand our research and clinical trials, recruit additional professionals in the field, and continue to advance pediatric and adolescent rehabilitation in Israel and around the world,” says ALYN Hospital’s Director General Dr. Maurit Beeri. “The field of child rehabilitation has not received enough attention due to it being relatively limited,” explains Dr. Beeri. “By establishing this research center at the ALYN Hospital, in collaboration with our best researchers, doctors and senior therapists from various health fields, we will take a major step forward in the fields of research and development of technologies for the rehabilitation of children and adolescents.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Must Read

Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation

Ekso Bionics President and COO Scott Davis promoted to Chief Executive Officer; and Steven Sherman to remain Chairman, appointed Executive Chair.

Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.

"Endoluminal surgery is an emerging field and a core focus for our Endoscopy business," said Mike Jones, senior vice president and president, Endoscopy, Boston Scientific. "We intend to expand our global capabilities in ELS with the differentiated innovation that Apollo Endosurgery offers, and we will continue to focus on procedural adoption as well as professional education in this exciting space. This acquisition also enables us to enter a new adjacency – the endobariatric market – and deliver strong, continued growth across our business."

Momentis Announces First Adoption of Anovo™ Surgical System in Texas by Medical City Plano

Dvir Cohen, CEO and Co-Founder of Momentis. “In the months ahead, we will continue our efforts to broaden availability of the system and improve gynecological surgery to enable more surgeons to perform the clinically preferred transvaginal approach, setting a higher standard in women’s healthcare.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy